P95her2-positive Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-03-13
Clinical Trial Update: A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer [Phase 2]
A Phase II randomized trial comparing lapatinib plus chemotherapy versus trastuzumab plus chemotherapy in HER2-positive and p95HER2-positive…